Tech Company Financing Transactions
ProThera Biologics Funding Round
ProThera Biologics, based in East Providence, secured $250 thousand from Slater Technology Fund.
Transaction Overview
Company Name
Announced On
9/30/2012
Transaction Type
Venture Equity
Amount
$250,000
Round
Undisclosed
Investors
Slater Technology Fund (Richard Horan)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
349 Eddy St.
East Providence, RI 02903
USA
East Providence, RI 02903
USA
Phone
Website
Email Address
Overview
The mission of the company is to develop novel products that exploit the promise of personalized medicine by leveraging on its proprietary technology of natural serine protease inhibitor proteins.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Yow-Pin Lim
President
Denice Spero
Browse more venture capital transactions:
Prev: 9/30/2012: Instructure venture capital transaction
Next: 9/30/2012: Purfresh venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs